Repligen Stock (RGEN)
Track Repligen stock through TheStreet Pro's latest coverage, including articles, Daily Diary mentions, TheStreet Pro portfolio activity, contributor watchlist signals, and Pro price levels.
RGEN
Repligen
healthcare
$180.71
▲ +60.43 (+49.84%) past year
Market Cap
$10.25B
P/E Ratio
245.4x
1Y Return
+49.84%
EPS (TTM)
$0.73
Read the latest TheStreet Pro articles mentioning Repligen, including market roundups, portfolio updates, trade ideas, and investing analysis.
Articles
1 articleDaily Diary Mentions
0 mentionsNo diary mentions for RGEN yet.